About IntegenX
IntegenX is a company based in Pleasanton (United States) founded in 2006 was acquired by Thermo Fisher Scientific in March 2018.. IntegenX has raised $92.06 million across 9 funding rounds from investors including Thermo Fisher Scientific, Square 1 Bank and HHS. The company has 78 employees as of December 31, 2017. IntegenX has completed 1 acquisition, including GenVault Corporation. IntegenX offers products and services including RapidHIT ID System and TaqMan Real-Time PCR Assays. IntegenX operates in a competitive market with competitors including DDC Paternity Tests, Othram, ANDE, Applied DNA Sciences and Ameritox, among others.
- Headquarter Pleasanton, United States
- Employees 78 as on 31 Dec, 2017
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Thermo Fisher Scientific Inc.
-
Annual Revenue
$22.5 B14513as on Dec 31, 2024
-
Net Profit
$6.34 B6as on Dec 31, 2024
-
EBITDA
$1.96 B2as on Dec 31, 2024
-
Total Equity Funding
$92.06 M (USD)
in 9 rounds
-
Latest Funding Round
$10 M (USD), Debt – Venture
Sep 22, 2014
-
Investors
Thermo Fisher Scientific
& 12 more
-
Employee Count
78
as on Dec 31, 2017
- Investments & Acquisitions
-
Acquired by
Thermo Fisher Scientific
(Mar 16, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of IntegenX
IntegenX offers a comprehensive portfolio of products and services, including RapidHIT ID System and TaqMan Real-Time PCR Assays. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Compact system for generating DNA profiles in forensic settings
Assays for DNA analysis in various scientific applications
Funding Insights of IntegenX
IntegenX has successfully raised a total of $92.06M across 9 strategic funding rounds. The most recent funding activity was a Debt – Venture round of $10 million completed in September 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Debt – Venture — $10.0M
-
First Round
First Round
(29 Aug 2006)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2014 | Amount | Debt – Venture - IntegenX | Valuation |
investors |
|
| Dec, 2012 | Amount | Series C - IntegenX | Valuation | EW Healthcare Partners | |
| Dec, 2011 | Amount | Debt – Conventional - IntegenX | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in IntegenX
IntegenX has secured backing from 13 investors, including venture fund and institutional investors. Prominent investors backing the company include Thermo Fisher Scientific, Square 1 Bank and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Structured debt is provided to life sciences and technology firms.
|
Founded Year | Domain | Location | |
|
Life science & tech focused VC firm investing in the US
|
Founded Year | Domain | Location | |
|
Expansion stage tech-focused VC firm investing primarily in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by IntegenX
IntegenX has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include GenVault Corporation. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Biosamples are stabilized, transported, stored, and retrieved by GenVault.
|
2000 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - IntegenX
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Integenx Comparisons
Competitors of IntegenX
IntegenX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DDC Paternity Tests, Othram, ANDE, Applied DNA Sciences and Ameritox, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
DNA tests and personalized diagnostics are provided for various specialties.
|
|
| domain | founded_year | HQ Location |
Genomic services are provided for forensic investigations and research.
|
|
| domain | founded_year | HQ Location |
Rapid DNA systems are provided for forensic identification and diagnostics.
|
|
| domain | founded_year | HQ Location |
Botanical-DNA-based security and authentication solutions are developed.
|
|
| domain | founded_year | HQ Location |
Pain medication monitoring solutions are provided for US clinicians.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Integenx
Frequently Asked Questions about IntegenX
When was IntegenX founded?
IntegenX was founded in 2006.
Where is IntegenX located?
IntegenX is headquartered in Pleasanton, United States. It is registered at Pleasanton, California, United States.
Is IntegenX a funded company?
IntegenX is a funded company, having raised a total of $92.06M across 9 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $5M, raised on Aug 29, 2006.
How many employees does IntegenX have?
As of Dec 31, 2017, the latest employee count at IntegenX is 78.
What is the annual revenue of IntegenX?
Annual revenue of IntegenX is $22.5B as on Dec 31, 2024.
What does IntegenX do?
Founded in 2006 and based in Pleasanton, United States, IntegenX operates in the forensics and law enforcement sector. Advanced fluidics, optics, and biochemistry are integrated into its proprietary platforms to create sample-to-answer products for DNA-based identity testing. As of January 2016, the RapidHIT ID and RapidHIT System, along with supporting reagent kits, are offered for these applications.
Who are the top competitors of IntegenX?
IntegenX's top competitors include DDC Paternity Tests, Key Forensic Services and Applied DNA Sciences.
What products or services does IntegenX offer?
IntegenX offers RapidHIT ID System and TaqMan Real-Time PCR Assays.
How many acquisitions has IntegenX made?
IntegenX has made 1 acquisition, including GenVault Corporation.
Who are IntegenX's investors?
IntegenX has 13 investors. Key investors include Thermo Fisher Scientific, Square 1 Bank, HHS, Horizon Tech Finance, and Western Technology Investment.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.